Polytechnique Fe News Today

A Ludwig Cancer Research study has shown that combining adoptive T cell therapy (ACT) with an innovative, personalized cancer vaccine under development at the Lausanne Branch of the Ludwig Institute for Cancer Research can benefit patients with late-stage, drug-resistant ovarian cancer.

Financial Times: Some places have decided to act over complaints of overcrowding.

Complaints about overcrowding and cultural insensitivity are getting louder. Now some destinations have decided to act.